✓ No loaded language, vague sourcing, or framing detected.
In two international studies, researchers found that about 20% of patients treated with an experimental Hepatitis B drug for six months had their virus levels reduced sufficiently for the immune system to control it. The findings suggest potential for a functional cure in some patients.
Our neutral summary
In two international studies, researchers found that about 20% of patients treated with an experimental Hepatitis B drug for six months had their virus levels reduced sufficiently for the immune system to control it. The findings suggest potential for a functional cure in some patients.
The reporting belongs to PBS NewsHour; we don't reproduce it.
No note attached
on this article.
Hepatitis B drug may offer 'functional cure' for some patients
Study finds experimental drug reduces Hepatitis B virus levels in some patients